Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2009
02/11/2009EP1109577B1 Multicomponent vaccines against Staphylococcus aureus
02/11/2009CN101365702A Inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications
02/11/2009CN101365699A Pyrido(3,2-D)pyrimidines and pharmaceutical compositions useful for medical treatment
02/11/2009CN101365475A Treatment of multiple sclerosis using interferon-tau
02/11/2009CN101365463A Antacid
02/11/2009CN101365444A Immunomodulatory pharmaceutical composition containing a combination of three coumarinolignoids
02/11/2009CN101365443A Antialergic agent, and food and drink, external preparation and cosmetic containing it
02/11/2009CN101365421A Substance for restoring normal co-expression and interaction between LOX and NRAGE proteins
02/11/2009CN101362805A Extraction of astragalus polysaccharide and molecular modification method thereof
02/11/2009CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
02/11/2009CN101361918A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep
02/11/2009CN101361917A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep
02/11/2009CN101361916A Traditional Chinese medicine preparation for enhancing immunity and promoting sleep
02/11/2009CN101361904A Traditional Chinese medicine prescription for treating allergic rhinitis
02/11/2009CN101361903A Traditional Chinese medicine prescription for treating elder kidney asthenia
02/11/2009CN101361881A Use of Chinese potato as protein medicine lysozyme intestinal-tract sorbefacient
02/11/2009CN101361864A Natural cordyceps sinensis oil
02/11/2009CN101361857A Nasal cavity surface preparation
02/11/2009CN101361774A Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof
02/11/2009CN101361764A Composition containing brown alga polysaccharide sulfuric ester and glossy ganoderma polysaccharide and use thereof
02/11/2009CN101361757A Combination containing brown alga polysaccharide sulfuric ester and propolis and use thereof
02/11/2009CN101361755A Extraction technique of Shengmu Rutai immunological active substance and capsules production method
02/11/2009CN101361722A Tacrolimus sustained release tablets and preparation method thereof
02/11/2009CN101361703A Sirolimos sustained and controlled release preparation and preparation method thereof
02/11/2009CN100460391C Chemical compounds.
02/11/2009CN100460019C Microparticles comprising carbohydrate beads covalently linked with allergen
02/11/2009CN100460015C Immunological regulator and application thereof
02/11/2009CN100459987C Effective part of astragalus, preparing method and application in pharmacy
02/11/2009CN100459984C Medicinal composition for pet care and preparing method thereof
02/11/2009CN100459880C Health food containing chitin and preparing method thereof
02/10/2009US7488809 Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic interest
02/10/2009US7488802 agonists and/or antagonists of PD-1 (Programmed Death 1) thereby modulate immune responses; treating autoimmune diseases, inflammatory disorders, allergies, transplant rejection, cancer
02/10/2009US7488712 Histone deacetylase inhibitors and methods for producing the same
02/10/2009US7488491 Use of glycosylceramides as adjuvants for vaccines against infections and cancer
02/10/2009US7488487 Administering an auxotropic attenuation strain of Listeria which expresses an antigen; induction immunology response; anticancer agents
02/10/2009US7488484 Multimeric protein fo treating and preventing viral infection; immunosuppressant
02/10/2009CA2389709C Pyrrole derivatives as phosphodiesterase vii inhibitors
02/10/2009CA2386690C Pharmaceutical tramadol salts
02/10/2009CA2358448C Dispersible concentrate for the delivery of cyclosporin
02/10/2009CA2344086C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
02/10/2009CA2339299C Method of modulating memory effector t-cells and compositions
02/10/2009CA2328396C New substituted amides, their production and their use
02/10/2009CA2301907C Treatment of cell-mediated immune diseases
02/10/2009CA2288601C Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
02/10/2009CA2208671C Substituted imides as tnf inhibitors
02/10/2009CA2186511C Pyrimidinyl derivatives as interleukin inhibitors
02/05/2009WO2009018441A1 Anti-cd28 antibodies for prolonging graft survival and treating type 1 diabetes
02/05/2009WO2009018326A2 Soluble pyrone analogs methods and compositions
02/05/2009WO2009017255A1 Method for specific regulation of toll-like receptor/interleukin-18 signaling by mutation-introduced myd88 protein
02/05/2009WO2009017236A1 Pyridopyrimidin-4-one derivatives
02/05/2009WO2009017219A1 Inhibitor of binding of s1p1
02/05/2009WO2009017161A1 Inhibitory agent for inflammatory cytokine
02/05/2009WO2009015543A1 Cyclohexenone compounds from antrodia camphorata and pharmaceutical compositions thereof useful for treating autoimmune diseases
02/05/2009WO2009015447A2 Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders
02/05/2009WO2008054606A3 High affinity human antibodies to human il-4 receptor
02/05/2009WO2003099808A8 Substituted heterocyclic compounds and methods of use
02/05/2009US20090036523 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
02/05/2009US20090036519 Peroxisome proliferator activated receptor ligand and process for producing the same
02/05/2009US20090036501 2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha
02/05/2009US20090036491 Transdermal pharmaceutical delivery compositions
02/05/2009US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
02/05/2009US20090036453 Pyrrolopyridazinone Compound
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
02/05/2009US20090036430 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment
02/05/2009US20090036423 Immunosuppresant compounds and compositions
02/05/2009US20090036419 Compounds useful as raf kinase inhibitors
02/05/2009US20090036412 Methods and Compositions for Inhibition of Angiogenesis
02/05/2009US20090036411 Modulation of cell fates and activities by phthalazinediones
02/05/2009US20090036410 Structured Phospholipids
02/05/2009US20090036374 Hepatocyte growth factor receptor splice variants and methods of using same
02/05/2009US20090036367 Novel peptides of the respiratory syncytial virus (RSV) G protein and their use in a vaccine
02/05/2009US20090036360 Medicament containing activated antithrombin iii
02/05/2009US20090036351 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
02/05/2009US20090035360 Lyophilised antigen composition
02/05/2009US20090035322 Human Antibodies to Human CD20 and Method of Using Thereof
02/05/2009US20090035319 Antibodies Against C3a Receptor
02/05/2009US20090035316 Monoclonal Antibodies and Cell Surface Antigens for the Detection and Treatment of Small Cell Lung Cancer (SCLC)
02/05/2009US20090035313 Compounds
02/05/2009US20090035296 Compounds and methods for treatment and diagnosis of chlamydial infection
02/05/2009US20090035265 Compositions and Methods for Targeted Delivery of Factors
02/05/2009US20090035264 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities
02/05/2009DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases
02/05/2009CA2817054A1 Composition of tumour-associated peptides and related anti-cancer vaccine
02/05/2009CA2700004A1 Novel immunotherapy strategy
02/05/2009CA2695382A1 A fold-back diabody diphtheria toxin immunotoxin and methods of use
02/05/2009CA2695156A1 Vinyl-aryl derivatives for inflammation and immune-related uses
02/04/2009EP2020445A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
02/04/2009EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity
02/04/2009EP2020408A1 Pyrrole substituted 2-indolinone protein kinase inhibitors
02/04/2009EP2020243A1 Topically applicable pharmaceutical preparation
02/04/2009EP2020239A1 Use of IL-174 agonists for treating infectious diseases
02/04/2009EP2019826A1 Thiophene-carboxamides useful as inhibitors of protein kinases
02/04/2009EP0881906B2 Pharmaceutical composition for immunomodulation based on peptides and adjuvants
02/04/2009CN101360829A Fermentation and culture method, fermented plant extract, composition containing fermented plant extract, method for producing lipopolysaccharide and lipopolysaccharide
02/04/2009CN101360826A Anti-alpha2 integrin antibodies and their uses
02/04/2009CN101360823A Recombinant multivalent vaccine
02/04/2009CN101360741A Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
02/04/2009CN101358225A Method for preparing high sialic acid content immune globulin antibody and application
02/04/2009CN101357951A Method for extracting ganoderma lucidum fruitbody polysaccharide using ultrahigh pressure